1-3 of 3
James Zehnder
Close
Sort by
Journal Articles

Enkurin: a novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens

Sumanth Mosale Seetharam, Yi Liu, Jason Wu, Lenn Fechter, Kanagavel Murugesan, Holden Maecker, Jason Gotlib, James Zehnder, Ramasamy Paulmurugan, Anandi Krishnan
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5433–5445.
https://doi.org/10.1182/bloodadvances.2022008939
Published: 2023
Includes: Supplemental data
Journal Articles

Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy

Clinical Trials & Observations
Andrew Johnsrud, Juliana Craig, John Baird, Jay Spiegel, Lori Muffly, James Zehnder, John Tamaresis, Robert Negrin, Laura Johnston, Sally Arai, Judith Shizuru, Robert Lowsky, Everett Meyer, Wen-Kai Weng, Parveen Shiraz, Andrew Rezvani, Theresa Latchford, Crystal Mackall, David Miklos, Matthew Frank, Surbhi Sidana
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4465–4475.
https://doi.org/10.1182/bloodadvances.2021004716
Published: 2021
Includes: Supplemental data
Journal Articles

A novel activating JAK1 mutation in chronic eosinophilic leukemia

William Shomali, Alisa Damnernsawad, Talent Theparee, David Sampson, Quinlan Morrow, Fei Yang, Sebastian Fernandez-Pol, Richard Press, James Zehnder, Jeffrey W. Tyner, Jason Gotlib
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3581–3586.
https://doi.org/10.1182/bloodadvances.2021004237
Published: 2021
Includes: Supplemental data